New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 27, 2013
05:52 EDTAMPEAmpio initiates clinical trial of Optina in DME, first patient dosed
Ampio Pharmaceuticals announced oral dosing of the first patient in a 505b2 clinical trial of the investigational drug Optina in diabetic macular edema, or DME. The trial will evaluate Optina in adults with recent onset diabetic macular edema. Last year, the FDA granted Optina 505b2 status and drugs designated under this pathway can be approved on a single trial.
News For AMPE From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
November 19, 2014
07:11 EDTAMPESociety for Free Radical Biology and Medicine to hold annual meeting
Subscribe for More Information
November 12, 2014
09:21 EDTAMPEOn The Fly: Pre-market Movers
Subscribe for More Information
08:12 EDTAMPEAmpio's Ampion vials will be manufactured in 1Q15
Subscribe for More Information
08:11 EDTAMPEAmpio updates status of clinical trials and manufacturing facility
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use